iShares Biotechnology ETF $IBB Stock Position Increased by BNP Paribas Financial Markets

BNP Paribas Financial Markets lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 11.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,133,461 shares of the financial services provider’s stock after purchasing an additional 218,066 shares during the period. BNP Paribas Financial Markets owned about 4.33% of iShares Biotechnology ETF worth $360,064,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $25,000. Basepoint Wealth LLC acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $26,000. Cary Street Partners Financial LLC acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $29,000. Copia Wealth Management acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $34,000. Finally, Cornerstone Planning Group LLC acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $35,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.0%

NASDAQ IBB opened at $172.18 on Friday. The company has a 50 day moving average price of $169.35 and a two-hundred day moving average price of $170.34. iShares Biotechnology ETF has a 12-month low of $120.33 and a 12-month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were paid a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.